Article Type
Changed
Wed, 06/01/2022 - 12:29

Key clinical point: A diet containing red meat did not have any significant effect on most glycemic and insulinemic risk factors associated with type 2 diabetes (T2D), but it led to a significant reduction in postprandial glucose level compared with a diet containing less or no red meat.

 

Major finding: A diet with vs without or less meat had no significant effect on insulin sensitivity (standardized mean difference [SMD] 0.11; 95% CI −0.39 to 0.16), insulin resistance (SMD 0.11; 95% CI −0.24 to 0.45), fasting glucose level (SMD 0.13; 95% CI −0.04 to 0.29), and fasting insulin level (SMD 0.08; 95% CI −0.16 to 0.32), but it significantly reduced the postprandial glucose level (SMD 0.44; P < .001).

 

Study details: Findings are from a meta-analysis of 21 randomized controlled trials that evaluated the association between red meat intake and T2D risk.

 

Disclosures: This study was funded by the Beef Checkoff. Three authors declared being employees of Midwest Biomedical Research (USA), which received research funding from Beef Checkoff and National Pork Board.

 

Source: Sanders LM et al. Red meat consumption and risk factors for type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Eur J Clin Nutr. 2022 (May 5). Doi: 10.1038/s41430-022-01150-1

Publications
Topics
Sections

Key clinical point: A diet containing red meat did not have any significant effect on most glycemic and insulinemic risk factors associated with type 2 diabetes (T2D), but it led to a significant reduction in postprandial glucose level compared with a diet containing less or no red meat.

 

Major finding: A diet with vs without or less meat had no significant effect on insulin sensitivity (standardized mean difference [SMD] 0.11; 95% CI −0.39 to 0.16), insulin resistance (SMD 0.11; 95% CI −0.24 to 0.45), fasting glucose level (SMD 0.13; 95% CI −0.04 to 0.29), and fasting insulin level (SMD 0.08; 95% CI −0.16 to 0.32), but it significantly reduced the postprandial glucose level (SMD 0.44; P < .001).

 

Study details: Findings are from a meta-analysis of 21 randomized controlled trials that evaluated the association between red meat intake and T2D risk.

 

Disclosures: This study was funded by the Beef Checkoff. Three authors declared being employees of Midwest Biomedical Research (USA), which received research funding from Beef Checkoff and National Pork Board.

 

Source: Sanders LM et al. Red meat consumption and risk factors for type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Eur J Clin Nutr. 2022 (May 5). Doi: 10.1038/s41430-022-01150-1

Key clinical point: A diet containing red meat did not have any significant effect on most glycemic and insulinemic risk factors associated with type 2 diabetes (T2D), but it led to a significant reduction in postprandial glucose level compared with a diet containing less or no red meat.

 

Major finding: A diet with vs without or less meat had no significant effect on insulin sensitivity (standardized mean difference [SMD] 0.11; 95% CI −0.39 to 0.16), insulin resistance (SMD 0.11; 95% CI −0.24 to 0.45), fasting glucose level (SMD 0.13; 95% CI −0.04 to 0.29), and fasting insulin level (SMD 0.08; 95% CI −0.16 to 0.32), but it significantly reduced the postprandial glucose level (SMD 0.44; P < .001).

 

Study details: Findings are from a meta-analysis of 21 randomized controlled trials that evaluated the association between red meat intake and T2D risk.

 

Disclosures: This study was funded by the Beef Checkoff. Three authors declared being employees of Midwest Biomedical Research (USA), which received research funding from Beef Checkoff and National Pork Board.

 

Source: Sanders LM et al. Red meat consumption and risk factors for type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Eur J Clin Nutr. 2022 (May 5). Doi: 10.1038/s41430-022-01150-1

Publications
Publications
Topics
Article Type
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Article Series
Clinical Edge Journal Scan: Type 2 DM June 2022
Gate On Date
Tue, 05/24/2022 - 16:45
Un-Gate On Date
Tue, 05/24/2022 - 16:45
Use ProPublica
CFC Schedule Remove Status
Tue, 05/24/2022 - 16:45
Hide sidebar & use full width
render the right sidebar.
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Display the Slideshow in this Article
Medscape Article
Display survey writer
Reuters content
Disable Inline Native ads
WebMD Article